Medicine and Dentistry
Heart Death
100%
Partial Nephrectomy
100%
Kidney Transplantation
92%
Cystectomy
83%
Robot-Assisted Prostatectomy
83%
Delayed Graft Function
71%
Retrospective Study
50%
Neoplasm
45%
Recurrent Disease
39%
Da Vinci Surgical System
36%
Prostate Cancer
35%
Kidney Tumour
34%
Bleeding
33%
Neoadjuvant Chemotherapy
33%
Retroperitoneal Lymph Node Dissection
33%
Overall Survival
31%
Graft Survival
26%
Cancer Specific Survival
26%
Biological Marker
22%
Bladder Cancer
22%
Long Term Survival
20%
Sacrocolpopexy
20%
Recurrence Free Survival
19%
Radical Nephrectomy
19%
Operation Duration
19%
Urinary Diversion
18%
Postoperative Ileus
18%
Survival Rate
18%
Glomerular Filtration Rate
17%
Ischemia
17%
Legionella
16%
Contrast-Enhanced Ultrasound
16%
Brain Death
16%
Ileal Conduit
16%
Cardiopulmonary Resuscitation
16%
Protein Z
16%
Inferior Vena Cava
16%
Transitional Cell Carcinoma
16%
Cell-Free DNA
16%
Biopsy
16%
Thrombectomy
16%
Computer Assisted Tomography
16%
Calcineurin
16%
Pyonephrosis
16%
Tissue Inhibitor of Metalloproteinase 1
16%
Isograft
16%
Heart Muscle Ischemia
16%
Brachytherapy
16%
Graft Failure
16%
Pancreas Transplantation
16%
Keyphrases
Kidney Transplantation
33%
Delayed Graft Function
33%
Donation after Cardiac Death
33%
Organ Recovery
33%
Robot-assisted Radical Prostatectomy
33%
Postoperative Day
22%
Graft Thrombosis
16%
Total Cell-free DNA
16%
Contrast-enhanced Ultrasonography
16%
Digestive System Cancer
16%
Robot-assisted Radical Nephrectomy
16%
Ureteritis
16%
Type I Diabetes
16%
Inferior Vena Cava Thrombectomy
16%
Glucagon Stimulation Test
16%
Liver-type Fatty Acid-binding Protein (L-FABP)
16%
Critical Risk Factors
16%
Human Leukocyte antigen-G (HLA-G)
16%
Graft Function
16%
Pentafecta Outcomes
16%
Intracorporeal Ileal Conduit
16%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
16%
Kidney Donor Profile Index
16%
Kidney Donor Risk Index
16%
Human NK Cells
16%
HLA-E
16%
CD94
16%
NKG2
16%
Selective Clamping
16%
Partial Nephrectomy
16%
Computed Tomography
16%
Porcine Endothelial Cells
16%
Premature Termination Codon
16%
Pyonephrosis
16%
Robot-assisted Laparoscopic Partial Nephrectomy
16%
RNA Kinetics
16%
Localized Kidney Cancer
16%
Surgical Systems
16%
Bladder Eversion
16%
Vesicoureteral Reflux
16%
Non-invasive Biomarkers
16%
Renal Scarring
16%
Swine Leukocyte Antigen
16%
Secondary Bladder Cancer
16%
Ureteroscope
16%
Localized Amyloidosis
16%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
16%
Single-center Experience
16%
Female Stress Urinary Incontinence
16%
Clinical Kidney Transplantation
16%